Equity Profile

CYRX

Cryoport, Inc.

Health CareLife Sciences Tools & Services$766.3M

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Cryoport, Inc. is a healthcare company specializing in life sciences tools and services, particularly in the area of temperature-controlled logistics for biopharmaceuticals....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.18

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$48M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CYRX Q2-2026 Earnings Preview

Context

Company Snapshot

Cryoport, Inc. is a healthcare company specializing in life sciences tools and services, particularly in the area of temperature-controlled logistics for biopharmaceuticals. As the demand for advanced therapies grows, Cryoport's role in ensuring the safe transport of sensitive biological materials becomes increasingly important.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+98.90%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, Cryoport reported an EPS of $-0.25, which was worse than the expected $-0.20. The stock reacted negatively, dropping 1.35% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are expecting a slight improvement in EPS and revenue this quarter compared to the previous one. The consensus estimates suggest cautious optimism.

Bull Case

If Cryoport can exceed expectations and show a path to profitability, it could signal strong demand for its services and boost investor confidence.

Bear Case

Conversely, if the company misses its targets again, it could raise concerns about its operational efficiency and market position.

Key Metrics to Watch

EPS

$-0.18

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$48M

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS come in better than the consensus estimate of $-0.18?

A better-than-expected EPS could indicate improving profitability and operational efficiency, which is crucial for investor confidence.

What are the revenue figures relative to the expected $48M?

Revenue performance is critical to understanding market demand and the company's growth trajectory.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Cryoport to improve its operational efficiency, which could lead to better-than-expected results this quarter.

Supporting Evidence

The options market is pricing a 25.97% move, suggesting that traders expect significant volatility, which could indicate underlying uncertainty.

Cryoport's historical performance shows that it has occasionally surprised positively, indicating potential for upside.

Key Risk

If the company reports revenue significantly above $48M, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Cryoport can demonstrate a turnaround in financial performance.

Bull Confirmed If

An EPS of $-0.17 or better, along with revenue exceeding $49M, would confirm the bull case.

Bear Confirmed If

An EPS worse than $-0.20 and revenue below $47M would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±25.97%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±26.0% while CYRX has averaged ±3.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

69.4%

Calls (307K)P/C Ratio: 0.00Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cryoport beats expectations, history suggests a potential stock increase of around 1.99%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a drop in stock price, with historical patterns suggesting an average decline of about 2.78%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Management's commentary on operational improvements and cost management strategies.
3Insights into market demand for Cryoport's services in the biopharmaceutical sector.
4Any guidance on future earnings expectations or financial targets.
5Responses to analyst questions regarding competitive pressures in the life sciences tools market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Cryoport, Inc. is a healthcare company specializing in life sciences tools and services, particularly in the area of temperature-controlled logistics for biopharmaceuticals....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.18

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$48M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CYRX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+98.90%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, Cryoport reported an EPS of $-0.25, which was worse than the expected $-0.20. The stock reacted negatively, dropping 1.35% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are expecting a slight improvement in EPS and revenue this quarter compared to the previous one. The consensus estimates suggest cautious optimism.

Bull Case

If Cryoport can exceed expectations and show a path to profitability, it could signal strong demand for its services and boost investor confidence.

Bear Case

Conversely, if the company misses its targets again, it could raise concerns about its operational efficiency and market position.

Key Metrics to Watch

EPS

$-0.18

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$48M

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS come in better than the consensus estimate of $-0.18?

A better-than-expected EPS could indicate improving profitability and operational efficiency, which is crucial for investor confidence.

What are the revenue figures relative to the expected $48M?

Revenue performance is critical to understanding market demand and the company's growth trajectory.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Cryoport to improve its operational efficiency, which could lead to better-than-expected results this quarter.

Supporting Evidence

The options market is pricing a 25.97% move, suggesting that traders expect significant volatility, which could indicate underlying uncertainty.

Cryoport's historical performance shows that it has occasionally surprised positively, indicating potential for upside.

Key Risk

If the company reports revenue significantly above $48M, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Cryoport can demonstrate a turnaround in financial performance.

Bull Confirmed If

An EPS of $-0.17 or better, along with revenue exceeding $49M, would confirm the bull case.

Bear Confirmed If

An EPS worse than $-0.20 and revenue below $47M would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±25.97%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±26.0% while CYRX has averaged ±3.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

69.4%

Calls (307K)P/C Ratio: 0.00Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cryoport beats expectations, history suggests a potential stock increase of around 1.99%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a drop in stock price, with historical patterns suggesting an average decline of about 2.78%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Management's commentary on operational improvements and cost management strategies.
3Insights into market demand for Cryoport's services in the biopharmaceutical sector.
4Any guidance on future earnings expectations or financial targets.
5Responses to analyst questions regarding competitive pressures in the life sciences tools market.